Ozlem Yildiz Selected Research

Ozlem Yildiz Research Topics

3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2021
3	Multiple Sclerosis 01/2021 - 09/2011
2	Disease Progression 01/2023 - 11/2018
1	COVID-19 05/2023
1	Inflammation (Inflammations) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2019
1	Acute-Phase Reaction 11/2018
1	Demyelinating Diseases (Demyelinating Disease) 09/2011
1	Weight Loss (Weight Reduction) 06/2011
1	Anorexia 06/2011
1	Nausea 06/2011
1	Sleepiness 06/2011
1	Abdominal Pain (Pain, Abdominal) 06/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2011
1	Priapism 07/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2008
1	Neoplasms (Cancer) 08/2008

3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	Cladribine FDA LinkGeneric 01/2021 - 04/2018
2	Ferritins (Ferritin)IBA 05/2023 - 01/2022
2	Methylphenidate (Ritalin)FDA LinkGeneric 06/2011 - 07/2010
1	fibrin fragment D (D-dimer)IBA 05/2023
1	CD18 AntigensIBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	chitotriosidaseIBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	DipeptidesIBA 01/2021
1	AntibodiesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ProteomeIBA 11/2018
1	Tissue Inhibitor of Metalloproteinase-2IBA 09/2011
1	CuprizoneIBA 09/2011
1	Metalloproteases (Metalloproteinases)IBA 09/2011
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2011
1	Messenger RNA (mRNA)IBA 09/2011
1	Matrix Metalloproteinases (MMPs)IBA 09/2011
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 06/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2008

2	Therapeutics 01/2023 - 08/2008